Business briefs: Amgen and Wockhardt

Share this article:

Rebounding from its failed Onyx courtship, Amgen announced Tuesday that it has paired up with Servier in a deal that will give it some heft in the cardiovascular space. The collaboration, which garners a $50-million signing fee for Servier, gives Amgen commercial rights to the oral chronic heart failure drug ivabradine, which is approved in the EU under the brand name Procoralan, as well as the exclusive option to develop Servier's S38844, a Phase II heart failure drug. In exchange, Servier scored rights to commercialize Amgen's Phase II heart failure drug omecamtiv in Europe. 

Indian generic drug maker Wockhardt has been locked out of European drug markets. Bloomberg reports that the drug maker's Waluj factory failed to meet UK guidelines. The FDA shut down the company's US distribution from this same plant in May, a move Bloomberg said is forecast to cost the manufacturer around $100 million in sales.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.